Please do not adjust margins
Organic & Biomolecular Chemistry
Page 10 of 11
COMMUNICATION
Journal Name
(E)-methyl 15-chloro-13-oxo-12-(p-tolyl)-10a,13-dihydro-10
H-benzo[7,8]chromeno[3',2':5,6]azocino[1,2-a]indole-11-car-
boxylate (3w). Yellow solid; obtained in 3.5 h and purified by
chromatography on silica gel (petroleum ether/ethyl acetate =
DOI: 10.1039/D0OB01626H
Conflicts of interest
There are no conflicts to declare.
o
1
7:1); 73.9 mg (67% yield); mp 153-155 C. H NMR (400 MHz,
CDCl3): δ 8.09 (d, J = 2.0 Hz, 1H), 7.63-7.55 (m, 2H), 7.46-7.39
(m, 3H), 7.19-7.13 (m, 4H), 7.04 (d, J = 7.6 Hz, 3H), 6.93 (d, J =
8.0 Hz, 1H), 6.77-6.73 (m, 1H), 5.53 (dd, J = 11.2, 9.6 Hz, 1H),
3.44 (s, 3H), 3.30-3.23 (m, 1H), 3.16 (dd, J = 15.6, 9.2 Hz, 1H),
2.27 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 174.69, 167.99,
163.97, 155.39, 147.02, 144.90, 141.68, 138.55, 134.84,
134.41, 134.10, 131.72, 131.59, 130.46, 129.74, 129.00,
127.95, 127.42, 127.27, 125.60, 125.21, 124.78, 124.39,
124.13, 122.83, 120.15, 119.82, 108.94 , 65.49, 51.64, 33.91,
20.98. HRMS (ESI) calcd for C34H25ClNO4 [M+H]+ 546.1467,
found 546.1480.
Acknowledgements
We thank the National Natural Science Foundation of China
(Grant No. 21871087) and the Natural Science Foundation of
Shandong Province (Grant no. ZR2018BB026) for financial
support.
Notes and references
1
(a) S. P. Roche and J. A. Porco Jr., Angew. Chem. Int. Ed., 2011, 50,
4068; Angew. Chem., 2011, 123, 4154. (b) C.-X. Zhuo, W. Zhang and
S.-L. You, Angew. Chem. Int. Ed., 2012, 51, 12662; Angew. Chem.,
2012, 124, 12834. (c) S. P. Roche, J.-J. Y. Tendoung and B. Tréguier,
Tetrahedron., 2015, 71, 3549. (d) N. Denizot, T. Tomakinian, R.
Beaud, C. Kouklovsky and G. Vincent, Tetrahedron Lett., 2015, 56,
4413. (e) Y. Wang, F. Xie, B. Lin, M. Cheng and Y. Liu, Chem. - Eur. J.,
2018, 24, 14302. (f) K. Li, T. P. Gonçalves, K.-W. Huang and Y. Lu,
Angew. Chem. Int. Ed., 2019, 58, 5427; Angew. Chem., 2019, 131,
5481. (g) J. M. Saya, E. Ruijter and R. V. A. Orru, Chem. - Eur. J., 2019,
25, 8916.
(a) I. S. Marcos, R. F. Moro, I. Costales, P. Basabe and David Díez,
Nat. Prod. Rep., 2013, 30, 1509. (b) P. Rongved, G. Kirsch, Z. Bouaziz,
J. Jose and M. L. Borgne, Eur. J. Med. Chem., 2013, 69, 465. (c) C.
Avendañoa, E. Caballeroa, C. Méndez-Vidalb, A. R. de Quesadab and
J. C. Menéndez, Lett. Drug Des. Disvov., 2006, 3, 369. (d) A. Ramírez
and S. García-Rubio, Cur. Med. Chem., 2003, 10, 1891. (e) S. M.
Verbitski, C. L. Mayne, R. A. Davis, G. P. Concepcion and C. M. Ireland,
J. Org. Chem., 2002, 67, 7124. (f) M. S. Baliga, Integr. Cancer Ther.,
2010, 9, 261. (g) P. Ruiz-Sanchis, S. A. Savina, F. Albericio and
Mercedes Álvarez, Chem. - Eur. J., 2011, 17, 1388. (h) A. Aygün and U.
Pindur, Curr. Med.Chem., 2003, 10, 1113. (i) M. Ishikura, T. Abe, T.
Choshib and S. Hibino, Nat. Prod. Rep., 2015, 32, 1389. (j) L. Peng, D.
Xu, X. Yang, J. Tang, X. Feng, S.-L. Zhang and H. Yan, Angew. Chem.
Int. Ed., 2019, 58, 216.
For selected reviews, see: (a) M. Murakami and Y. Ito, Top.
Organomet. Chem., 1999, 3, 97. (b) C.-H. Jun, Chem. Soc. Rev., 2004,
33, 610. (c) G. B. Dong, Topics in Current Chemistry, Springer, Berlin,
2014, vol. 346. (d) F. Chen, T. Wang and N. Jiao, Chem. Rev., 2014,
114, 8613. (e) K. Ruhland, Eur. J. Org. Chem., 2012, 2683. (f) L.
Souillart and N. Cramer, Chem. Rev., 2015, 115, 9410. For selected
recent examples, see: (g) T. Seiser and N. Cramer, J. Am. Chem. Soc.,
2010, 132, 5340. (h) A. Yada, S. Fujita and M. Murakami, J. Am. Chem.
Soc., 2014, 136, 7217. (i) H. M. Ko and G. B. Dong, Nat. Chem., 2014,
6, 739. (j) S. K. Murphy, J.-W. Park, F. A. Cruz and V. M. Dong, Science,
2015, 347, 56. (k) M. Weber, K. Owens, A. Masarwa and R. Sarpong,
Org. Lett., 2015, 17, 5432. (l) I. Saidalimu, S. Suzuki, E. Tokunaga and
N. Shibata, Chem. Sci., 2016, 7, 2106. (m) L. Deng, T. Xu, H. B. Li and
G. B. Dong, J. Am. Chem. Soc., 2016, 138, 369. (n) C. A. Malapit, N.
Ichiishi and M. S. Sanford, Org. Lett., 2017, 19, 4142. (o) N. Ichiishi, C.
A. Malapit, Ł. Woźniak and M. S. Sanford, Org. Lett., 2018, 20, 44. (p)
F. Hu, L. Wang, L. Xua and S-S Li, Org. Chem. Front., 2020, 7, 1570.
(a) T.-S. Kam, K. Yoganathan and C.-H. Chuah, Tetrahedron Lett.,
1995, 36,759. (b) T.-S. Kam, K.-H. Lim, K. Yoganathan, M. Hayashi
and K. Komiyama, Tetrahedron., 2004, 60,10739. (c) S. Arai, M.
Nakajima and A. Nishida, Angew. Chem. Int. Ed., 2014, 35, 5569. (d)
M. Nakajima, S. Arai and A. Nishida, Chem. Asian J., 2015, 10, 1065.
(e) S. Arai, M. Nakajima and A. Nishida, Alkaloids Chem. Biol., 2017,
78, 167. (f) M. Hoshi, O. Kaneko, M. Nakajima, S. Arai and A. Nishida,
Org. Lett., 2014, 16,768. (g) M. S. Kirillova, M. E. Muratore, R. Dorel
and A. M. Echavarren, J. Am. Chem. Soc., 2016, 138, 3671.
(E)-methyl 15-chloro-12-(4-methoxyphenyl)-13-oxo-10a,13-
dihydro-10H-benzo[7,8]chromeno[3',2':5,6]azocino[1,2-a]in-
dole-11-carboylate (3x). Yellow solid; obtained in 3.5 h and
purified by chromatography on silica gel (petroleum
ether/ethyl acetate = 5:1); 81.5 mg (73% yield); mp 160-162
1
oC. H NMR (400 MHz, CDCl3): δ 8.09 (d, J = 2.0 Hz, 1H), 7.62-
7.55 (m, 2H), 7.45-7.39 (m, 3H), 7.24-7.12 (m, 5H), 7.05-7.01
(m, 1H), 6.92 (d, J = 7.6 Hz, 1H), 6.77-6.73 (m, 3H), 5.52 (dd, J =
11.2, 9.6 Hz, 1H), 3.73 (s, 3H), 3.45 (s, 3H), 3.29-3.25 (m, 1H),
3.15 (dd, J = 15.6, 9.2 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ
174.69, 168.05, 163.93, 159.92, 155.37, 146.98, 144.46,
141.71, 134.40, 133.77, 131.70, 131.57, 130.39, 130.03,
129.72, 129.44, 127.39, 127.23, 125.54, 125.18, 124.75,
124.36, 124.07, 122.80, 120.16, 119.80, 113.58, 108.91, 65.49,
54.96, 51.63, 33.90. HRMS (ESI) calcd for C34H25ClNO5 [M+H]+
562.1416, found 562.1420.
(Z)-methyl 7-(3-(2-bromophenyl)-3-oxo-1-(p-tolyl)prop-1-
en-1-yl)-5-hydroxyindolo[1,2-a]quinoline-6-carboxylate (5a).
Yellow solid; purified by chromatography on silica gel
(petroleum ether/ethyl acetate = 15:1); mp 182-184 oC. 1H
NMR (400 MHz, CDCl3): δ 12.54 (s, 1H), 8.28 (dd, J = 14.0, 8.0
Hz, 2H), 8.01 (d, J = 8.0 Hz, 1H), 7.74-7.70 (m, 1H), 7.62-7.60
(m, 2H), 7.40-7.36 (m, 1H), 7.25-7.14 (m, 5H), 7.00 (s, 1H), 6.71
(d, J = 8.0 Hz, 1H), 6.58 (d, J = 7.2 Hz, 1H), 6.47-6.43 (m, 1H),
6.24-6.20 (m, 1H), 3.43 (s, 3H), 2.40 (s, 3H); 13C NMR (100 MHz,
CDCl3): δ 196.19, 170.43, 161.72, 150.69, 140.94, 140.43,
138.61, 136.77, 133.06, 132.93, 132.42, 131.88, 130.71,
129.59, 128.71, 128.71, 128.01, 126.10, 125.40, 124.80,
123.23, 122.40, 122.00, 120.91, 118.53, 117.88, 115.53,
113.27, 107.46, 97.06, 50.84, 21.12. HRMS (ESI) calcd for
C34H25BrNO4 [M+H]+ 590.0961, found 590.0972.
2
3
Methyl
5-hydroxyindolo[1,2-a]quinoline-6-carboxylate
(6a). Yellow solid; purified by chromatography on silica gel
(petroleum ether/ethyl acetate = 30:1); mp 134-136 oC. 1H
NMR (400 MHz, CDCl3): δ 13.21 (s, 1H), 8.43 (d, J = 8.8 Hz, 1H),
8.26-8.23 (m, 2H), 7.75-7.67 (m, 2H), 7.33-7.31 (m, 3H), 7.08 (s,
1H), 4.08 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 172.19, 162.08,
139.22, 133.01, 132.63, 132.37, 131.44, 126.11, 122.79,
122.24, 121.30, 120.65, 117.92, 115.47, 113.96, 97.75, 96.48,
52.39. HRMS (ESI) calcd for C18H14NO3 [M+H]+ 292.0968, found
292.0972.
4
10 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins